1. Home
  2. NOVT vs KRYS Comparison

NOVT vs KRYS Comparison

Compare NOVT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOVT
  • KRYS
  • Stock Information
  • Founded
  • NOVT 1968
  • KRYS 2015
  • Country
  • NOVT United States
  • KRYS United States
  • Employees
  • NOVT N/A
  • KRYS N/A
  • Industry
  • NOVT Industrial Machinery/Components
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NOVT Miscellaneous
  • KRYS Health Care
  • Exchange
  • NOVT Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • NOVT 5.1B
  • KRYS 4.6B
  • IPO Year
  • NOVT N/A
  • KRYS 2017
  • Fundamental
  • Price
  • NOVT $136.54
  • KRYS $184.88
  • Analyst Decision
  • NOVT Hold
  • KRYS Strong Buy
  • Analyst Count
  • NOVT 1
  • KRYS 7
  • Target Price
  • NOVT $160.00
  • KRYS $220.00
  • AVG Volume (30 Days)
  • NOVT 274.8K
  • KRYS 297.9K
  • Earning Date
  • NOVT 05-06-2025
  • KRYS 05-05-2025
  • Dividend Yield
  • NOVT N/A
  • KRYS N/A
  • EPS Growth
  • NOVT N/A
  • KRYS 669.23
  • EPS
  • NOVT 1.77
  • KRYS 3.00
  • Revenue
  • NOVT $949,245,000.00
  • KRYS $290,515,000.00
  • Revenue This Year
  • NOVT $7.24
  • KRYS $60.34
  • Revenue Next Year
  • NOVT $7.07
  • KRYS $47.35
  • P/E Ratio
  • NOVT $79.52
  • KRYS $61.25
  • Revenue Growth
  • NOVT 7.67
  • KRYS 473.02
  • 52 Week Low
  • NOVT $136.02
  • KRYS $141.72
  • 52 Week High
  • NOVT $187.12
  • KRYS $219.34
  • Technical
  • Relative Strength Index (RSI)
  • NOVT 36.29
  • KRYS 62.94
  • Support Level
  • NOVT $136.02
  • KRYS $175.98
  • Resistance Level
  • NOVT $144.08
  • KRYS $182.16
  • Average True Range (ATR)
  • NOVT 4.87
  • KRYS 7.28
  • MACD
  • NOVT -0.31
  • KRYS 0.57
  • Stochastic Oscillator
  • NOVT 3.03
  • KRYS 77.20

About NOVT Novanta Inc.

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: